Last Updated: September 24, 2026

Details for New Drug Application (NDA): 210884

✉ Email this page to a colleague

NDA 210884 describes TOSYMRA, which is a drug marketed by Tonix Meds and is included in one NDA. It is available from two suppliers. There are nine patents protecting this drug. Additional details are available on the TOSYMRA profile page.

The generic ingredient in TOSYMRA is sumatriptan. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.

Summary for 210884

Tradename:	TOSYMRA
Applicant:	Tonix Meds
Ingredient:	sumatriptan
Patents:	9

Pharmacology for NDA: 210884

Mechanism of Action	Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists

Medical Subject Heading (MeSH) Categories for 210884

Serotonin 5-HT1 Receptor Agonists
Vasoconstrictor Agents

Suppliers and Packaging for NDA: 210884

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TOSYMRA	sumatriptan	SPRAY;NASAL	210884	NDA	Upsher-Smith Laboratories, LLC	0245-0812	0245-0812-61	6 BLISTER PACK in 1 CARTON (0245-0812-61) / 1 BOTTLE, SPRAY in 1 BLISTER PACK (0245-0812-89) / .1 mL in 1 BOTTLE, SPRAY (0245-0812-59)
TOSYMRA	sumatriptan	SPRAY;NASAL	210884	NDA	Tonix Medicines, Inc.	70792-812	70792-812-59	1 BLISTER PACK in 1 CARTON (70792-812-59) / 1 BOTTLE, SPRAY in 1 BLISTER PACK / .1 mL in 1 BOTTLE, SPRAY

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SPRAY;NASAL			Strength	10MG/SPRAY
Approval Date:	Jan 25, 2019	TE:		RLD:	Yes
Patent:	⤷ Start Trial	Patent Expiration:	Jun 16, 2030	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	ACUTE TREATMENT OF MIGRAINE
Patent:	⤷ Start Trial	Patent Expiration:	Jun 16, 2030	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	ACUTE TREATMENT OF MIGRAINE
Patent:	⤷ Start Trial	Patent Expiration:	Jun 16, 2030	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 210884

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Tonix Meds	TOSYMRA	sumatriptan	SPRAY;NASAL	210884-001	Jan 25, 2019	⤷ Start Trial	⤷ Start Trial
Tonix Meds	TOSYMRA	sumatriptan	SPRAY;NASAL	210884-001	Jan 25, 2019	⤷ Start Trial	⤷ Start Trial
Tonix Meds	TOSYMRA	sumatriptan	SPRAY;NASAL	210884-001	Jan 25, 2019	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.